通过药剂师的干预,避免了伤害和成本的避免,同时使用放电药物调和工具.
Abigail M Hoffman1, Jennifer L Walls2, Amanda Prusch2
1Department of Pharmacy, Wellspan York Hospital, York, PA, USA.
概括
药剂师使用出院药物调和工具进行干预,防止了对患者的重大伤害,避免了大量的成本. 这些关键干预措施,特别是高风险药物,在医疗保健环境中显然具有价值.
科学领域:
- 卫生经济学 卫生经济学
- 患者安全 患者安全
- 临床药房 临床药房
背景情况:
- 药物错误是可预防的患者伤害的重要来源.
- 有效的药物调和对于安全的患者过渡至关重要,特别是在出院时.
研究的目的:
- 量化在出院药物调和过程中药剂师干预造成的成本避免和预防伤害.
- 评估药剂师领导的药物调和流程的财务影响.
主要方法:
- 一个回顾性图表审查确定了药剂师发起的出院药物调和干预措施.
- 使用国家药物错误报告和预防协调委员会 (NCC MERP) 系统对差异进行了分类.
- 根据干预类型和相关风险计算成本避免.
主要成果:
- 药剂师进行了190次干预,可能避免了46958美元至231032美元的成本.
- 涉及高风险药物的干预措施在成本避免方面占到了33,920美元至147,203美元.
- 最顶级的避免成本的药物类别包括胰岛素,抗血栓剂和阿片类药物.
结论:
- 药剂师主导的出院药物调和有效地防止了对患者的伤害.
- 这些干预措施可以大大降低成本,凸显了它们在医疗保健系统中的价值.
相关概念视频
01:19Pharmacovigilance
866
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
866
01:31Discharge Summary Forms
769
The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
769
01:15Methods of Documentation VI: Case Management Model
586
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
586
01:18Guidelines and Strategies for Safe Computer Charting
817
The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
Maintain Confidentiality and Security:
817
01:28Drug Therapy
51
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
51
01:15Drug Dosage Regimen: Overview
3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K